Literature DB >> 9376190

Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990.

R J Black1, F Bray, J Ferlay, D M Parkin.   

Abstract

Members of the European Network of Cancer Registries (ENCR) provide population-based data on cancer incidence for some countries and regions of Europe. These were supplemented by estimates in order to provide comparable information on cancer incidence and mortality in the 15 member states of the European Union (EU). The estimated numbers of new cases of cancer (excluding nonmelanoma skin cancer) in 1990 were approximately 706,900 in men and 644,200 in women. Approximately 497,500 men and 398,200 women died of cancer in the same year. The main sites of incident cases in men were lung (21%), large bowel (13%), prostate (12%), bladder (7%) and stomach (7%). For women, the predominant sites were breast (28%), large bowel (15%), lung (6%), uterine corpus (5%) and stomach (5%). The overall incidence rates for males were highest in continental Western Europe (France, The Netherlands, Austria, Luxembourg, Belgium, Germany and Italy) while the rates of Greece, Portugal, Sweden, Ireland, Spain, Finland, the U.K. and Denmark were below the average value for the EC. Rates for females were highest in Northern and Western Europe, with the exception of France, which had a relatively low rate for females, in common with Greece, Spain and Portugal. The geographical variations in incidence of the major cancers are discussed in relation to risk factors. The estimates show the substantial burden of cancer in European Union populations, but there are also indications of effects of past preventive measures and there is scope for further intervention. Cancer registries are an important source of information for cancer control since they provide population-based incidence and survival statistics. These, along with mortality data, are required to obtain a full picture of the frequency of cancer and its effects at the population level. Some 44% of the EU population is covered by registries. The European Network of Cancer Registries aims to standardise the information provided by existing registries and to provide practical assistance to those in development.

Entities:  

Mesh:

Year:  1997        PMID: 9376190     DOI: 10.1016/s0959-8049(96)00492-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  65 in total

Review 1.  Screening for cervical cancer: a review of women's attitudes, knowledge, and behaviour.

Authors:  F Fylan
Journal:  Br J Gen Pract       Date:  1998-08       Impact factor: 5.386

2.  [Incidence of cancer, survival and demand for secondary care in the towns of Fisterra and Corcubión (A Coruña)].

Authors:  S Pita Fernández; M J Platero Castro; S Pértega Díaz; E Feijoo Fernández
Journal:  Aten Primaria       Date:  2003-03-15       Impact factor: 1.137

Review 3.  Mediterranean diet, olive oil and cancer.

Authors:  Ramón Colomer; Javier A Menéndez
Journal:  Clin Transl Oncol       Date:  2006-01       Impact factor: 3.405

4.  A hierarchical non-homogenous Poisson model for meta-analysis of adenoma counts.

Authors:  Carolyn M Rutter; Onchee Yu; Diana L Miglioretti
Journal:  Stat Med       Date:  2007-01-15       Impact factor: 2.373

5.  [Clinical utility of serous tumoural markers].

Authors:  A Martín Suárez; L Alonso Díaz; I Ordiz Alvarez; J Vázquez; F Vizoso Piñeiro
Journal:  Aten Primaria       Date:  2003       Impact factor: 1.137

Review 6.  Prostate cancer in the elderly.

Authors:  Hatzimouratidis Konstantinos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

7.  Olive oil, diet and colorectal cancer: an ecological study and a hypothesis.

Authors:  M Stoneham; M Goldacre; V Seagroatt; L Gill
Journal:  J Epidemiol Community Health       Date:  2000-10       Impact factor: 3.710

Review 8.  Insulin: a novel agent in the pathogenesis of prostate cancer.

Authors:  Hanumanthappa Nandeesha
Journal:  Int Urol Nephrol       Date:  2008-07-30       Impact factor: 2.370

9.  Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head.

Authors:  Quentin Denost; Christophe Laurent; Jean-Philippe Adam; Maylis Capdepont; Veronique Vendrely; Denis Collet; Antonio Sa Cunha
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

10.  Benefit of whole pelvic radiotherapy combined with neoadjuvant androgen deprivation for the high-risk prostate cancer.

Authors:  Piotr Milecki; Maciej Baczyk; Janusz Skowronek; Andrzej Antczak; Zbigniew Kwias; Piotr Martenka
Journal:  J Biomed Biotechnol       Date:  2009-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.